Thus, we postulate that hsa-miR-20b-5p and hsa-miR-363-3p, might act as oncomiRs when overexpressed in T-ALL and we indicate PTEN and BIM as potential important mediators of these effects. This evidence concerns the gene BCL2L11 and acute lymphoblastic leukemia.